Thiamet G as a Potential Treatment for Polycystic Kidney Disease

doi:10.21873/invivo.13360

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/34923

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34923

題名:	Thiamet G as a Potential Treatment for Polycystic Kidney Disease
作者:	Su, Wen-Cheng Hung, Chi-Feng Wang, Yi-Chieh Peng, Hubert Huang, Wen-Hung Lo, Yi-Lun Lo, Yun-Hwa Chen, Yi-Cheng Su, Hsin-Hui Chen, Yung-Liang
貢獻者:	Yuan Pei Univ Med Technol, Dept Med Lab Sci & Biotechnol Chia yi Christian Hosp, Ditmanson Med Fdn, Dept Urol Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol Acad Sinica, Inst Mol Biol Natl Yang Ming Chiao Tung Univ, Coll Med, Inst Pharmacol Kaohsiung Med Univ, Coll Life Sci, Dept Med & Appl Chem Natl Pingtung Univ Sci & Technol, Dept Vet Med Chia Nan Univ Pharm & Sci, Dept Pharm Yuan Pei Univ Sci & Technol, Dept Med Lab Sci & Biotechnol Chia Nan Univ Pharm & Sci, Dept Pharm
關鍵詞:	Autosomal dominant polycystic kidney disease ADPKD O-linked N-acetylglucosamine Thiamet G
日期:	2023
上傳時間:	2024-12-25 11:05:42 (UTC+8)
出版者:	INT INST ANTICANCER RESEARCH
摘要:	Background/Aim: Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent genetic disorder primarily caused by mutations in Pkd1 (PC1), which account for the majority of ADPKD cases. These mutations contribute to the formation of cysts in the kidneys and other organs, ultimately leading to renal failure. Unfortunately, there are currently no available preventive treatments for this disease. Materials and Methods: In this study, we utilized Pkd1-knockdown mice and cells to investigate the potential involvement of O-GlcNAcylation in the progression of PKD. Additionally, we examined the effects of thiamet G, an inhibitor of O-GlcNAcase (OGA), on PKD mice. Results: Our findings indicate that both O-GlcNAcylation and OGT (O-GlcNAc transferase) were downregulated in the renal tissues of Pkd1-silenced mice. Furthermore, OGlcNAcylation was shown to regulate the stability and function of the C-terminal cytoplasmic tail (CTT) of PC1. Treatment of PKD mice with thiamet G resulted in a reduction of renal cytogenesis in these animals. Conclusion: These results highlight the unique role of O-GlcNAcylation in the development of cyst formation in PKD and propose it as a potential therapeutic target for the treatment of PKD.
關聯:	In Vivo, v.37, n.6, pp.2524-2532
顯示於類別:	[Dept. of Pharmacy] Periodical Articles

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	268	檢視/開啟
invivo.13360.pdf		2571Kb	Adobe PDF	114	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....